Yet Another Value Podcast cover image

Chris DeMuth's State of the Markets December 2023

Yet Another Value Podcast

00:00

Royvon's Trading Status and Intellectual Property Litigation

This chapter discusses the current state of Royvon, its structure as a subsidiary of Roy, the Vance, and its involvement in a litigation against Pfizer and Moderna, highlighting the potential value of intellectual property. It also explores the complex ownership structure of another subsidiary called Arbutus and compares the market size of Nurbutus, Moderna, and Pfizer.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app